{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Macular+Dystrophy%2C+Corneal&page=2", "query": { "condition": "Macular Dystrophy, Corneal", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Macular+Dystrophy%2C+Corneal&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-23T14:19:43.454Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00065611", "title": "Steroid Treatment for Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nephrosis", "Focal Lipoid Glomerulosclerosis" ], "interventions": [ { "name": "Oral dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 8, "start_date": "2003-07", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2011-10-28", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00065611" }, { "nct_id": "NCT04023123", "title": "Anterior Corneal Striae in Hypotony", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypotony Ocular", "Cornea Folds and Rupture of Bowman's Membrane Both Eyes", "Maculopathy" ], "interventions": [ { "name": "Ophthalmic imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2019-09-17", "completion_date": "2020-03-23", "has_results": false, "last_update_posted_date": "2020-05-05", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04023123" }, { "nct_id": "NCT05626478", "title": "Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Corneal Edema", "Corneal Defect", "Anterior Chamber Inflammation", "Ocular Pain", "Corneal Staining", "Visual Outcome", "CME - Cystoid Macular Edema" ], "interventions": [ { "name": "Dextenza 0.4Mg Ophthalmic Insert", "type": "DRUG" }, { "name": "Prednisolone Acetate 1% Oph Susp", "type": "DRUG" }, { "name": "Prolensa 0.07% Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nicole Fram M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2023-06-01", "completion_date": "2025-02-05", "has_results": false, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05626478" }, { "nct_id": "NCT05003986", "title": "Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Focal Segmental Glomerulosclerosis", "Minimal Change Disease", "Immunoglobulin A Nephropathy", "IgA Vasculitis", "Alport Syndrome" ], "interventions": [ { "name": "Sparsentan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Travere Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "17 Years", "sex": "ALL", "summary": "1 Year to 17 Years" }, "enrollment_count": 67, "start_date": "2021-08-12", "completion_date": "2027-04-12", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 23, "location_summary": "Los Angeles, California • Wilmington, Delaware • Miami, Florida + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT05003986" }, { "nct_id": "NCT04009668", "title": "Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "FSGS", "MCD", "Focal Segmental Glomerulosclerosis", "Minimal Change Disease" ], "interventions": [ { "name": "adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "6 Years to 80 Years" }, "enrollment_count": 7, "start_date": "2019-10-02", "completion_date": "2023-10-03", "has_results": true, "last_update_posted_date": "2024-10-30", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 4, "location_summary": "Ann Arbor, Michigan • New York, New York • Charlotte, North Carolina + 1 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04009668" }, { "nct_id": "NCT06983028", "title": "Atacicept in Multiple Glomerular Diseases", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "pMN", "IgAN", "Nephrotic Syndrome", "MCD", "FSGS" ], "interventions": [ { "name": "Atacicept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vera Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 250, "start_date": "2025-07-07", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Brisbane, California", "locations": [ { "city": "Brisbane", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06983028" }, { "nct_id": "NCT00092222", "title": "Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphoproliferative Disorder", "HHV-8", "Malignancy", "HIV" ], "interventions": [ { "name": "Etoposide", "type": "DRUG" }, { "name": "Interferon-alpha", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" }, { "name": "Liposomal Doxorubicin", "type": "DRUG" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Valganciclovir", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Filgrastim (G-CSF)", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Observation Only", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2004-10-28", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00092222" }, { "nct_id": "NCT04853251", "title": "A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neovascular Age-related Macular Degeneration" ], "interventions": [ { "name": "PDS Implant With Ranibizumab 100 mg/ml", "type": "DEVICE" }, { "name": "LUCENTIS (Ranibizumab Injection)", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 188, "start_date": "2021-12-14", "completion_date": "2027-10-29", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 52, "location_summary": "Mesa, Arizona • Bakersfield, California • Huntington Beach, California + 47 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04853251" }, { "nct_id": "NCT02423213", "title": "DISCOVER Study: Microscope-integrated Intraoperative OCT Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Retinal Diseases", "Fuchs Endothelial Dystrophy", "Macular Hole", "Epiretinal Membrane", "Retinal Detachment" ], "interventions": [], "intervention_types": [], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3000, "start_date": "2014-01", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02423213" }, { "nct_id": "NCT00559234", "title": "Potential Research Participants for Future Studies of Inherited Eye Diseases", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cataract", "Glaucoma", "Retinitis Pigmentosa", "Macular Degeneration", "Strabismus" ], "interventions": [], "intervention_types": [], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 400, "start_date": "2007-11-09", "completion_date": "2008-10-03", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-07-23T14:19:43.454Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00559234" } ] }